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Summary  37 
   38 
Objective: To report mode of delivery and immediate neonatal outcome in COVID-19 39 
infected women.  40 
 41 
Design: This is a retrospective study..  42 
 43 
Setting: Twelve hospitals in northern Italy. 44 
 45 
Participants: Pregnant women with COVID-19 confirmed infection who delivered.   46 
 47 
Exposure: COVID 19 infection in pregnancy.  48 
 49 
Methods:SARS-CoV-2 infected women who were admitted and delivered during the period 50 
1-20 march 2020 were eligible. Data were collected from the clinical records using a 51 
standardized questionnaire on maternal general characteristics, any medical or obstetric co-52 
morbidity,  evolution of pregnancy, clinical signs and symptoms, treatment of COVID 19 53 
infection, mode of delivery, neonatal data and  breastfeeding 54 
 55 
Main Outcome and Measure: Data on mode of delivery and neonatal outcome  56 
 57 
Results: 42 women with COVID-19 delivered at the participating centres:  24(57,1%, 95% 58 
CI= 41,0-72,3) delivered vaginally.  An elective cesarean section was performed in 18/42 59 
(42,9%, 95%CI 27,7-59,0) cases: in 8 cases the indication was unrelated to COVID-19 60 
infection. Pneumonia was diagnosed in 19/42(45,2%, 95%CI 29,8-61,3) cases: of these 61 
7/19(36,8%,95CI 16,3-61,6) required oxygen support and 4/19(21,1%,95%CI=6,1-45,6) 62 
were admitted to a critical care unit. Two women with COVID-19   breastfed without  a mask 63 
because infection was diagnosed in the post-partum period:  their new-borns tested positive 64 
for SARS-Cov-2 infection. In one case a new-born had a positive test after a vaginal 65 
operative delivery.  66 
 67 
Conclusions:.  Although post-partum infection cannot be excluded with 100% certainty, 68 
these findings suggest that vaginal delivery is associated with a low  risk of 69 
intrapartum  SARS-Cov-2 transmission to the new-born.  70 
   71 
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INTRODUCTION.  88 
 89 
Most of the information on the effect of COVID-19 infection during pregnancy is based on 90 
data relating to other highly pathogenic coronaviruses (i.e., severe acute respiratory 91 
syndrome (SARS) and the Middle East respiratory syndrome(MERS) 1. 92 
  93 
Recently Chen et al.2 have reported nine cases of deliveries in women with COVID-19 94 
pneumonia. In their study all nine patients had a caesarean section in the third trimester. 95 
The neonatal outcomes were favourable and all neonatal throat swabs performed tested 96 
negative for the virus.   97 
 98 
Another clinical series of 11 women with COVID 19 infection who  had successful 99 
deliveries (10 cesarean and 1 vaginal) has been reported: in all the new-borns  the 2019-100 
nCoV nucleic acid test was  negative3.  101 
 102 
Chen et al concluded their paper by underlining that “there is currently no evidence for 103 
intrauterine infection caused by vertical transmission in women who develop COVID-19 104 
pneumonia in late pregnancy” 2.  This finding is, however, based on very few reported 105 
cases, particularly for vaginally delivered newborns3,4. Accordingly, a recent consensus 106 
stated that there is no clear evidence regarding optimal delivery timing, the safety of 107 
vaginal delivery, or whether cesarean delivery prevents vertical transmission at the time of 108 
delivery; therefore, route of delivery and delivery timing should be individualized based on 109 
obstetrical indications and maternal-fetal status. 5  110 
 111 
Due to the recent outbreak of the infection in Italy, particularly in Lombardy, a number of 112 
infected women have already delivered.  Regione Lombardia, Northern Italy, has 113 
established a network of six designated COVID-19 maternity hospitals in order to offer 114 
adequate assistance and epidemiological surveillance to symptomatic infected pregnant 115 
women. 116 
The goal of this study was to report the mode of delivery and immediate neonatal outcome 117 
in SARS-CoV-2 infected women observed in the early phase of the epidemic in Lombardy  118 
   119 
 120 
   121 
METHODS.  122 
 123 
We performed a retrospective  multicenter  study of  COVID-19 infected women who were 124 
admitted and delivered during the period 1-20 march 2020.  Most deliveries of infected 125 
women occurred in the designated COVID-19 hubs, but some were delivered in spoke 126 
hospitals because they were in advanced active phase labour. Designated Hub-Maternity 127 
Hospitals were: Milan-Mangiagalli and Sacco,  Bergamo-Pap Giovanni XXIII; Brescia-128 
Spedali Civili; Monza-S. Gerardo Hospital/MBBM Foundation; Pavia-San Matteo. Spokes 129 
Maternity Hospitals were:  Milan-Melloni and S. Giuseppe; Seriate-Bolognini; Treviglio-Civil 130 
Hospital.  The Maternity Hospital of Padua and the Maternity Hospital of Modena were not 131 
hub hospitals of Lombardy Region, but also reported their cases for this study”.  132 
 133 
Criteria for entry to the study were:  134 
-pregnant women who delivered during the study period with a confirmed diagnosis of 135 
COVID-19 infection prior to or within 36 hours after delivery. 136 
 137 
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The investigators reported all women consecutively observed who met the inclusion 138 
criteria. 139 
All centers carefully revised all delivery charts of the study period and all cases who had a 140 
confirmed throat swab by RT-PCR positive  test for SARS-CoV-2 infection were included. 141 
The clinical triage was performed according to WHO guidelines6. Diagnosis of COVID 19 142 
infection was based on the results of maternal and child throat swab samples according to 143 
Italian National Procedures7. All women were treated according to the National Guidelines 144 
for COVID-19 in pregnancy and treatment was then tailored according to the individual 145 
evolution of signs, symptoms, laboratory data and radiologic findings. There were no 146 
additional obstetric diagnostic procedures or monitoring in addition to normal clinical 147 
practice, apart from a confirmative chest x-ray, and 48 hours monitoring of white blood cell 148 
count and CRP.  149 
 150 
Fetal growth and well-being were assessed at admission and the fetal heart rate was 151 
monitored continuously during labour and delivery. 152 
  153 
Surgical mask for the labouring woman, her accompanying person and the midwife and/or 154 
doctor were worn during labours. More strict personal protective equipment (PPE) were 155 
worn during delivery ,as bearing down expulsive efforts risk may cause the woman to emit 156 
infected droplets. 157 
 158 
When the positive infected status of the mother was known at delivery, breast feeding was 159 
allowed according to international guidelines8 if the mother was asymptomatic or had only 160 
minor symptoms. Women were instructed how to wear and dispose of surgical masks, in 161 
combination with frequent hand-cleaning with alcohol-based hand rub or soap and water. 162 
  163 
Data were collected from the clinical records using a standardised questionnaire on 164 
maternal general characteristics, any medical or obstetric co-morbidity, course of 165 
pregnancy, clinical signs and symptoms, treatment of COVID 19 infection, mode of 166 
delivery, neonatal data and  breastfeeding. In relation to the neonatal outcome, we 167 
recorded only whether there was a positive or negative test for COVID-19. Women and 168 
new-borns were followed up until discharge from hospital or till March 25th, whatever came 169 
first. 170 
 171 
For the recorded variables, averages, range or proportion and corresponding 172 
95%confidence intervals (CI) were computed, as appropriate. Statistically significant 173 
differences among groups was tested using the common chi square test for heterogeneity.  174 
Patients were not involved in the development of the research. No core outcome set was 175 
used in the research. 176 
 177 
The study protocol was approved by the Institutional Review Boards.   178 
No funding supports this study 179 
   180 
 181 
 182 
RESULTS.  183 
 184 
A total of  42 women eligible for the study delivered in the participating centres.A total of 185 
32 women delivered at hub hospitals and 10 in the spoke ones.  186 
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Diagnosis of COVID-19 infection was known before admission to hospital in 10 cases, in 187 
the delivery room in 27 cases and in 5 cases the diagnosis was made within 36 hours 188 
following delivery, while the women were still in hospital.   189 
 190 
A total of 24/42 (57,1%, 95% CI= 41,0-72,3) women delivered vaginally, with three  cases 191 
undergoing induction of  labour for obstetric reasons. 192 
  193 
An elective cesarean section was performed in 18/42 (42,9%, 95%CI 27,7-59,0) cases: in 194 
8 cases the indication was unrelated to COVID-19 infection, but in 10 cases the indications 195 
were worsening dyspnoea or other COVID-19 related symptoms. In women who attempted 196 
vaginal delivery, no emergency cesarean section occurred  197 
 198 
  199 
The  characteristics, signs, symptoms and treatment of COVID-19 infection of this 200 
cohort  are presented in table 1 according to the mode of delivery. Mean maternal age was 201 
32.9 (range 21-44). Fever was the most common symptom. Pneumonia was diagnosed in 202 
19/42 (45,2%, 95%CI 29,8-61,3) cases. 7 of these 19 (36,8%,95CI 16,3-61,6) required 203 
oxygen support and 4 of the 19 (21,1%,95%CI=6,1-45,6 ) were admitted to a critical care 204 
unit. Pneumonia was more common in women who delivered by caesarean section due to 205 
COVID-19 related infection (chi-square=7.45, p-value= 0,024). 206 
 207 
Table 2 presents the course of pregnancy and the neonatal outcome. Gestational diabetes 208 
was reported in 6/42 cases (14%) without any significant difference between the three 209 
groups. 30/42 (71,4%, 95%CI=55,4-84,3) women delivered at term. Spontaneous preterm 210 
birth occurred in 5 cases and in 6 cases elective cesarean section was performed.  211 
 212 
Two very preterm new-borns had a 5min Apgar score <7; all the rest had 5 min Apgar 213 
scores of 7 or more. 214 
  215 
Newborn outcomes and breastfeeding. 216 
 217 
In 10 cases breastfeeding was allowed, with the women using a surgical mask. Two 218 
women had a new diagnosis of COVID-19 infection in the post-partum period 219 
and breastfed without a surgical mask; both the newborns had a positive test for COVID-220 
19 infection at day one and three,  respectively.    221 
In another case after vaginal delivery the new-born of an infected woman had a positive 222 
test. This case deserves additional details. One newborn from a COVID-19 mother 223 
delivered vaginally at term in good condition was immediately separated because of a 224 
severe maternal postpartum haemorrhage. Within a few hours he developed 225 
gastrointestinal symptoms, and after three days he developed respiratory symptoms and 226 
was transferred to the neonatal intensive care unit where he recovered after one day of 227 
mechanical ventilation. The first test for SARS-CoV-2 was equivocal a few hours after 228 
delivery, but positive three days later. The mother did not breastfeed. No associated health 229 
care providers had a confirmed diagnosis of COVID-19 infection. No other positive test 230 
was found among the newborns.  231 
 232 
 233 
   234 
 235 
 236 
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DISCUSSION. 237 
 238 
Main findings. 239 
 240 
This paper reports the obstetric outcome of a cohort of COVID-19 affected pregnant 241 
women and the rate of SARS-CoV-2 positivity in new-borns according to the mode of 242 
delivery and breastfeeding status 243 
The general results show that vaginal delivery occurred in about the 60% of women A 244 
low  risk of intrapartum  SARS-Cov-2 transmission to the new-born cannot be excluded.  245 
Further,  the majority of pregnant women affected by the COVID-19 respiratory syndromes 246 
suffered  mild or moderate  symptoms. Fever, cough and mild dyspnoea were the most 247 
common symptoms, (80%), but pneumonia was diagnosed in about the 40% of women. 248 
 249 
Strengths and limitations. 250 
 251 
Among the strengths of this analysis we have to consider  the fact that  we have included 252 
in our study all consecutive positive women delivered in, or admitted to the post-partum 253 
COVID-19 ward, in all maternity units of the COVID-network in Lombardy and  Units of 254 
Padua and Modena, so as to be sure to include all symptomatic cases who tested positive 255 
on the nasopharyngeal sampling. The reported cases represent approximately 0.6% of the  256 
total deliveries occurring in the same area during the 20 days of the study. 257 
Among the limitations we should underline that due to the limited follow up, the not 258 
immediate maternal and new-born outcome was not considered. 259 
 260 
Interpretation. 261 
 262 
In our study, the maternal conditions were generally mild to moderate. Radiologically 263 
confirmed pneumonia was diagnosed in 42% of cases and four of these 19 cases required 264 
admission to a critical care unit. As suggested by others9, the findings of our cohort 265 
support the hypothesis that COVID-19 respiratory syndrome may be less severe for 266 
maternal prognosis than SARS and MERS.  267 
Lymphopaenia and high CRP values were part of the clinical scenario that induced 268 
clinicians to deliver patients by cesarean section. 269 
  270 
Of note, two cases were delivered < 34 weeks of gestation because of worsening 271 
respiratory function. Five women delivered spontaneously before term (one before 34 272 
weeks of gestation). These observations are compatible with no increase in the risk of 273 
preterm birth, consistent with the findings of a previously published series reporting no 274 
cases of preterm birth before 33 weeks of gestation4.  275 
 276 
Vertical and intrapartum transmission are among the most serious complications of viral 277 
diseases during pregnancy. In the previously quoted published series of a total of 30 278 
women2,3, delivery in all but one cases was by cesarean section. No new-born infection 279 
was reported. Vertical transmission does not seem to occur after infection with other 280 
pathogenic coronaviruses such SARS-CoV and MERS-CoV- infection, although it has 281 
been suggested that coronaviruses may cause early pregnancy loss10,11.  282 
 283 
Previous data on virus transmission are based substantially on women delivered by 284 
cesarean section. Vertical transmission of viral infection generally occurs during 285 
intrauterine life by transfer across the placenta, or during delivery by ingestion or aspiration 286 
of cervicovaginal secretions, and in the postpartum period  via breastfeeding1. The risk of 287 
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ingestion or aspiration of cervical secretion or with contact with perineal infected tissue is 288 
of course higher in case of vaginal delivery. Among the 24 women who delivered vaginally, 289 
one new-born was infected probably due to post-partum contamination (see below).  In a 290 
second cases after vaginal delivery a potential intrapartum infection may have occurred, 291 
but it was not possible to exclude infection immediately post-partum. 292 
  293 
It should be emphasized that we can only consider the risk of transmission among women 294 
who were infected during the third trimester or at term and the risk of intrapartum 295 
transmission, because the infections in Northern Italy are all recent, and women infected in 296 
early pregnancy are still pregnant. 297 
   298 
We report five cases who were diagnosed to be  COVID-19 positive because of fever in 299 
the post-partum period. In two cases in which skin to skin contact after birth and 300 
breastfeeding was allowed without a mask because infection was not known, the COVID-301 
19 test of the new-born was positive at days 1 and 3 after birth.  Although no viral load has 302 
been detected in breast milk by Chan et al. 2, close maternal contact may represent a 303 
potential route of transmission. In these two cases, because viral testing was not carried 304 
out immediately after birth, vertical transmission cannot be excluded.  305 
To our knowledge, other two cases of SARS-CoV-2 infected new-borns have been 306 
reported in which the diagnosis was made 36 hours following delivery and at 17 days of 307 
life. In both cases a postpartum neonatal infection acquired through an infected contact 308 
was suggested 4.  In all these cases, because viral testing was not performed immediately 309 
after birth, the route of transmission cannot be definitely established. 310 
  311 
Elevated IGM antibodies against Coronavirus  have been also reported in a case after 312 
caesarean section by Dong et al 13. Three additional newborns with elevated IGM 313 
antibodies to SARS-COv-2 virus, but a throat swab by RT-PCR negative test, have been 314 
also reported 14. Caution in interpreting these findings has been suggested, including the 315 
possibility that IGM positivity could represent a laboratory artifact15.  316 
   317 
 318 
Conclusion. 319 
 320 
The frequency of COVID-19 symptoms and positive laboratory and radiologic findings 321 
observed in this cohort is in line with the fact that this syndrome is generally mild or 322 
moderate in pregnancy and very likely many infected pregnant women are totally 323 
asymptomatic or develop symptoms only after delivery. Vaginal delivery is appropriate in 324 
mild cases and caesarean section should be reserved for women with severe respiratory 325 
embarrassment where delivering the baby will allow improved ventilation. Although post-326 
partum infection cannot be excluded, our study  also  suggests that vaginal delivery may 327 
be  associated with a low  risk of intrapartum  SARS-Cov-2 transmission to the new-born. 328 
This finding needs further data. 329 
The observed occurrence of COVID-19 symptoms only after delivery suggests that, in 330 
areas characterized by a high prevalence of infection, safe procedures for midwives and 331 
doctors are to be recommended in any labour and to adopt mask and safe procedures in 332 
all breastfeeding women. 333 
   334 
   335 
 336 
 337 
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Table 1.  Maternal characteristics and symptoms. 434 
  Elective 
Cesarean section 
for conditions 
determined by 
COVID-19 
respiratory 
syndrome 
(No.= 10)  
Elective 
Cesarean 
section for 
obstetric 
reasons 
unrelated with 
COVID-19 
respiratory 
syndrome 
(No.=8) 
Vaginal delivery° 
(No.=24) 
Maternal characteristics    
Maternal age (mean, range) 30.9 (21-40) 30.5 (27-44) 34.6 (29-43) 
Nulliparous women 4(40%) 2(25%) 9 (38%) 
Sign and symptoms of SARS-
Cov-2-infection 
   
Fever before delivery 7(70%) 4(40%) 9(38%) 
Fever only in the post partum   - 1(13%) 5(21%) 
Myalgia/malaise 5(50%) - 2(8%) 
Cough 8(80%) 2(25%) 8(33%) 
Dyspnoea 7(70%) - 1(4%) 
Diarrhoea - 1(13%) 1(4%) 
Pneumonia 8(80%) 4(50%) 7(29%) 
Treatment    
Oxygen support (nasal cannula, 
CPAP) 
4(40%) 1(13%) 2(8%) 
Admission to critical care unit (yes) 2(20%) 1(13%) 1(4%) 
Laboratory findings    
High leukocyte count  
(>9.5 × 10⁹ cells per L)°° 
3(30%) 2(25%) 11(46%) 
Lymphopenia (<10⁹ cells per L)°°  3(30%) 1(13%) 2(8%) 
Elevated C-reactive protein (>10 
mg/L)°° 
7(70%) 4(50%) 6(25%) 
Elevated ALT (>45 U/L) or AST 
(>35 U/L)°° 
2(20%) - 3(13%) 
° In 3 cases labour was induced for obstetric indication unrelated with COVID 19 respiratory 435 
syndrome. °°6 cases missing 436 
 437 
 438 
 439 
 440 
 441 
 442 
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Table 2. Pregnancy, delivery and neonatal outcome. 443 
 Elective 
Cesarean 
section for 
conditions 
determined by 
COVID-19 
respiratory 
syndrome 
(No.= 10)   
Elective Cesarean 
section for obstetric 
reasons unrelated 
with COVID-19 
respiratory syndrome  
(No.=8) 
Vaginal delivery 
(No.=24) 
Pregnancy and delivery    
Gestational diabetes (yes) 2(20%) - 4 (17%) 
Weeks of gestation at delivery    
>37  5 (50%) 7(88%) 18( 78%)° 
>34-37 3 (30%) - 4 (17%) 
<=34 2 (20%) 1 (13%) 1 (4%) 
New-born    
Birth weight (grams; mean, range)°° 2730(840-4040) 3100(2770-3430) 3226(2450-3740) 
Apgar score (5min)>7 8(80%) 8(100%) 24(100%) 
NICU admission (Yes) - 1 (13%)°°° 2(8%)°°° 
Positivity to SARS-Cov-2  (Yes) 0 1(13%) 2(8%) 
Breastfeeding (Yes) 0 1(12%) 10(42%) 
NICU: Neonatal Intensive Care Unit. 444 
°1 case  missing 445 
°°5 cases missing 446 
°°° for preterm birth/respiratory distress 447 
 448 
